25-Hydroxycholesterol

25-Hydroxycholesterol is a lipid of Sterol Lipids (ST) class. 25-hydroxycholesterol is associated with abnormalities such as Hereditary Diseases, Atherosclerosis, Fatty Liver, Infection and Exanthema. The involved functions are known as Binding (Molecular Function), cholesterol binding, sterol binding, oxysterol binding and Regulation. 25-hydroxycholesterol often locates in Membrane, Golgi membrane, Cellular Membrane, Cytoplasmic matrix and Golgi Apparatus. The associated genes with 25-Hydroxycholesterol are PTPN7 gene, OSBP gene, N-glycylalanine, SCAP gene and TSPO gene. The related lipids are 25-hydroxycholesterol, Sterols, Hydroxycholesterols, 27-hydroxycholesterol and Steroids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of 25-Hydroxycholesterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 25-Hydroxycholesterol?

25-Hydroxycholesterol is suspected in Atherosclerosis, Keratoconjunctivitis Sicca, Hypercholesterolemia, Fatty Streak, Arterial, Hypochondroplasia (disorder), Infection and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 25-Hydroxycholesterol

MeSH term MeSH ID Detail
Arteriosclerosis D001161 86 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Atherosclerosis D050197 85 associated lipids
Total 4

PubChem Associated disorders and diseases

What pathways are associated with 25-Hydroxycholesterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 25-Hydroxycholesterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 25-Hydroxycholesterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 25-Hydroxycholesterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 25-Hydroxycholesterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 25-Hydroxycholesterol?

Knock-out

Knock-out are used in the study 'Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis.' (Schüle R et al., 2010) and Knock-out are used in the study 'SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth.' (Porstmann T et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with 25-Hydroxycholesterol

Download all related citations
Per page 10 20 50 100 | Total 873
Authors Title Published Journal PubMed Link
Chalubinski M et al. The effect of 7-ketocholesterol and 25-hydroxycholesterol on the integrity of the human aortic endothelial and intestinal epithelial barriers. 2013 Inflamm. Res. pmid:24077843
Elsabrouty R et al. Sterol-induced dislocation of 3-hydroxy-3-methylglutaryl coenzyme A reductase from membranes of permeabilized cells. 2013 Mol. Biol. Cell pmid:24025715
Schmidt AW et al. Inhibitory effect of oxygenated cholestan-3β-ol derivatives on the growth of Mycobacterium tuberculosis. 2013 Bioorg. Med. Chem. Lett. pmid:24084159
Zhang J et al. Effect of triptolide on progesterone production from cultured rat granulosa cells. 2012 Arzneimittelforschung pmid:22592319
Wang F et al. Interferon regulator factor 1/retinoic inducible gene I (IRF1/RIG-I) axis mediates 25-hydroxycholesterol-induced interleukin-8 production in atherosclerosis. 2012 Cardiovasc. Res. pmid:21979142
Sugiura H et al. Increased 25-hydroxycholesterol concentrations in the lungs of patients with chronic obstructive pulmonary disease. 2012 Respirology pmid:22295989
Rosca AM et al. Cardiomyocyte apoptosis in ischaemia-reperfusion due to the exogenous oxidants at the time of reperfusion. 2012 Cell Biol. Int. pmid:22994946
Koo MS et al. Strain specific transcriptional response in Mycobacterium tuberculosis infected macrophages. 2012 Cell Commun. Signal pmid:22280836
Aye IL et al. Oxysterols exert proinflammatory effects in placental trophoblasts via TLR4-dependent, cholesterol-sensitive activation of NF-κB. 2012 Mol. Hum. Reprod. pmid:22238372
Gold ES et al. ATF3 protects against atherosclerosis by suppressing 25-hydroxycholesterol-induced lipid body formation. 2012 J. Exp. Med. pmid:22473958
Nishigori M et al. Highly potent binding and inverse agonist activity of bisphenol A derivatives for retinoid-related orphan nuclear receptor RORγ. 2012 Toxicol. Lett. pmid:22659100
Kostopoulou F et al. Central role of SREBP-2 in the pathogenesis of osteoarthritis. 2012 PLoS ONE pmid:22662110
Koarai A et al. 25-Hydroxycholesterol enhances cytokine release and Toll-like receptor 3 response in airway epithelial cells. 2012 Respir. Res. pmid:22849850
Kivelä AM et al. Regulation of endothelial lipase and systemic HDL cholesterol levels by SREBPs and VEGF-A. 2012 Atherosclerosis pmid:23102786
Lange Y et al. Activation mobilizes the cholesterol in the late endosomes-lysosomes of Niemann Pick type C cells. 2012 PLoS ONE pmid:22276143
Bai Q et al. VEGF is involved in the increase of dermal microvascular permeability induced by tryptase. 2012 ISRN Dermatol pmid:22666607
Schumacher M et al. Progesterone synthesis in the nervous system: implications for myelination and myelin repair. 2012 Front Neurosci pmid:22347156
Corman A et al. Structure-activity relationships for side chain oxysterol agonists of the hedgehog signaling pathway. 2012 ACS Med Chem Lett pmid:24900386
Xu L et al. 25-Hydroxycholesterol-3-sulfate attenuates inflammatory response via PPARγ signaling in human THP-1 macrophages. 2012 Am. J. Physiol. Endocrinol. Metab. pmid:22275753
Pardali E and Ten Dijke P TGFβ signaling and cardiovascular diseases. 2012 Int. J. Biol. Sci. pmid:22253564
Lai YL et al. Inhibition of endothelial- and neuronal-type, but not inducible-type, nitric oxide synthase by the oxidized cholesterol metabolite secosterol aldehyde: Implications for vascular and neurodegenerative diseases. 2012 J Clin Biochem Nutr pmid:22247606
Bai Q et al. Oxysterol sulfation by cytosolic sulfotransferase suppresses liver X receptor/sterol regulatory element binding protein-1c signaling pathway and reduces serum and hepatic lipids in mouse models of nonalcoholic fatty liver disease. 2012 Metab. Clin. Exp. pmid:22225954
Goto A et al. Multisite phosphorylation of oxysterol-binding protein regulates sterol binding and activation of sphingomyelin synthesis. 2012 Mol. Biol. Cell pmid:22875984
Appelqvist H et al. Sensitivity to lysosome-dependent cell death is directly regulated by lysosomal cholesterol content. 2012 PLoS ONE pmid:23166840
Latif R et al. Steroidogenesis in amlodipine treated purified Leydig cells. 2012 Toxicol. Appl. Pharmacol. pmid:22032983
Yashiro T et al. Resveratrol increases the expression and activity of the low density lipoprotein receptor in hepatocytes by the proteolytic activation of the sterol regulatory element-binding proteins. 2012 Atherosclerosis pmid:22153697
Parisio G et al. Flip-flop of steroids in phospholipid bilayers: effects of the chemical structure on transbilayer diffusion. 2012 J. Am. Chem. Soc. pmid:22738146
Baker ME et al. 3D models of human ERα and ERβ complexed with 5-androsten-3β,17β-diol. 2012 Steroids pmid:22921477
Rodríguez-Carpena JG et al. Inhibition of cholesterol oxidation products (COPs) formation in emulsified porcine patties by phenolic-rich avocado (Persea americana Mill.) extracts. 2012 J. Agric. Food Chem. pmid:22292505
Roberg-Larsen H et al. High sensitivity measurements of active oxysterols with automated filtration/filter backflush-solid phase extraction-liquid chromatography-mass spectrometry. 2012 J Chromatogr A pmid:22410154
Guo J et al. HCV NS5A and NS5B enhance expression of human ceramide glucosyltransferase gene. 2012 Virol Sin pmid:22270805
Siam A et al. Comparative modeling of 25-hydroxycholesterol-7α-hydroxylase (CYP7B1): ligand binding and analysis of hereditary spastic paraplegia type 5 CYP7B1 mutations. 2012 J Mol Model pmid:21541746
Catarino S et al. Regulation of the expression of interleukin-8 induced by 25-hydroxycholesterol in retinal pigment epithelium cells. 2012 Acta Ophthalmol pmid:22313893
Yu PL et al. Antisteroidogenic effects of hydrogen peroxide on rat granulosa cells. 2012 Free Radic. Res. pmid:22397630
Bielska AA et al. Synthesis of the enantiomer of the oxysterol-antagonist LY295427. 2011 Sep-Oct Steroids pmid:21470559
Medina MW et al. Coordinately regulated alternative splicing of genes involved in cholesterol biosynthesis and uptake. 2011 PLoS ONE pmid:21559365
Thorsell AG et al. Comparative structural analysis of lipid binding START domains. 2011 PLoS ONE pmid:21738568
Rehman S et al. Antiviral drugs against hepatitis C virus. 2011 Genet Vaccines Ther pmid:21699699
Zhou T et al. OSBP-related protein 8 (ORP8) regulates plasma and liver tissue lipid levels and interacts with the nucleoporin Nup62. 2011 PLoS ONE pmid:21698267
Honda A et al. Cholesterol 25-hydroxylation activity of CYP3A. 2011 J. Lipid Res. pmid:21576599
Vejux A et al. Contribution of cholesterol and oxysterols in the physiopathology of cataract: implication for the development of pharmacological treatments. 2011 J Ophthalmol pmid:21577274
Shan PF et al. Apelin attenuates the osteoblastic differentiation of vascular smooth muscle cells. 2011 PLoS ONE pmid:21437254
Jo Y et al. Membrane-associated ubiquitin ligase complex containing gp78 mediates sterol-accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. 2011 J. Biol. Chem. pmid:21343306
Nantia EA et al. Effects of the methanol extract of Basella alba L (Basellaceae) on steroid production in Leydig cells. 2011 Int J Mol Sci pmid:21339992
Sonawane PJ et al. Functional promoter polymorphisms govern differential expression of HMG-CoA reductase gene in mouse models of essential hypertension. 2011 PLoS ONE pmid:21304971
den Uyl D et al. (Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis. 2011 Arthritis Res. Ther. pmid:21241491
Lappano R et al. The cholesterol metabolite 25-hydroxycholesterol activates estrogen receptor α-mediated signaling in cancer cells and in cardiomyocytes. 2011 PLoS ONE pmid:21304949
Jusakul A et al. Mechanisms of oxysterol-induced carcinogenesis. 2011 Lipids Health Dis pmid:21388551
Olsen BN et al. 25-Hydroxycholesterol increases the availability of cholesterol in phospholipid membranes. 2011 Biophys. J. pmid:21320439
Burgett AW et al. Natural products reveal cancer cell dependence on oxysterol-binding proteins. 2011 Nat. Chem. Biol. pmid:21822274